Antiprogestin Testing Act of 1993
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 5, 1993)
Antiprogestin Testing Act of 1993 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions of the Public Health Service Act relating to institutional review boards and peer review.
What just happenedFeb 3, 1993
Referred to the Subcommittee on Health and the Environment.
Who’s behind it
- Introduced in HouseJan 5, 1993
- Feb 3, 1993CommitteeH11000
Referred to the Subcommittee on Health and the Environment.
Health and Environment Subcommittee - Jan 5, 1993IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 5, 1993IntroReferralIntro-H
Introduced in House
- Jan 5, 1993IntroReferral1000
Introduced in House